Position in RVTY
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$392,859
New position
Shares Held
3,531
first reported quarter
Ownership
0.003%
of shares outstanding
% of Portfolio
0.15%
of 13F equity value
Holder Rank
#302
of 542 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 0%
Shared 0%
None 100%
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026ELEVATUS WELATH MANAGEMENT holds $3,470,975 across 6 Diagnostics & Research names. RVTY ranks #5 (11.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
2,352 | $1,179,198 | |
| 2 | DHR |
Danaher Corp /De/
|
3,246 | $618,298 | |
| 3 | NTRA |
Natera, Inc.
|
2,019 | $548,057 | |
| 4 | A |
Agilent Technologies, Inc.
|
3,795 | $504,089 | |
| 5 | RVTY |
Revvity, Inc.
This page
|
3,531 | $392,859 | |
| 6 | IDXX |
Idexx Laboratories Inc /De
|
434 | $228,474 |
All Filings in RVTY
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $392,859 | 3,531 | Shares | Sole | 2026-08-13 | |
| No filing history on record for this holder in this stock. | ||||||